The National Cancer Institute (NCI) is offering the Outstanding Investigator Award (R35) to support accomplished investigators across all cancer research areas. This grant provides long-term funding stability for researchers with exceptional productivity records. The purpose of this award is to empower investigators to take greater risks, pursue adventurous inquiries, or develop new techniques. It encourages projects with unusual potential that can break new ground or extend discoveries, leading to breakthroughs in biomedical, behavioral, or clinical cancer research. This initiative aims to advance cancer research through sustained support for high-impact, innovative endeavors.
Opportunity ID: 328305
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-20-278 |
| Funding Opportunity Title: | NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jul 23, 2020 |
| Last Updated Date: | Jul 23, 2020 |
| Original Closing Date for Applications: | Nov 06, 2020 |
| Current Closing Date for Applications: | Nov 06, 2020 |
| Archive Date: | Dec 12, 2020 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities City or township governments Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education For profit organizations other than small businesses Independent school districts Private institutions of higher education Small businesses Special district governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education State governments County governments Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) invites grant applications for the Outstanding Investigator Award (R35) in any area of cancer research. The objective of the National Cancer Institute (NCI) Outstanding Investigator Award (OIA) is to provide long-term support to accomplished investigators with outstanding records of cancer research productivity who propose to conduct exceptional research. The OIA is intended to allow investigators the opportunity to take greater risks, be more adventurous in their lines of inquiry, or take the time to develop new techniques. The OIA would allow an Institution to submit applications nominating established Program Directors/Principal Investigators (PDs/PIs) for the NCI OIA. It is expected that the OIA would provide extended funding stability and encourage investigators to embark on projects of unusual potential in cancer research. The research projects should break new ground or extend previous discoveries toward new directions or applications that may lead to a breakthrough that will advance biomedical, behavioral, or clinical cancer research. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-20-278.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00262729 | Oct 06, 2020 | Nov 06, 2020 | View |
Package 1
Mandatory forms
328305 RR_SF424_2_0-2.0.pdf
328305 PHS398_CoverPageSupplement_5_0-5.0.pdf
328305 RR_OtherProjectInfo_1_4-1.4.pdf
328305 PerformanceSite_2_0-2.0.pdf
328305 RR_KeyPersonExpanded_2_0-2.0.pdf
328305 RR_Budget10_1_4-1.4.pdf
328305 PHS398_ResearchPlan_4_0-4.0.pdf
328305 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
328305 RR_SubawardBudget10_30_1_4-1.4.pdf
328305 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
